Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH_BETAT_AG retinoblastoma tumors

References

• TamboliAPodgorMJHormJWThe incidence of retinoblastoma in the United States: 1974 through 1985Arch Ophthalmol199010811281322288550
   PubMedGoogle Scholar
• PendergrassTWDavisSIncidence of retinoblastoma in the United StatesArch Ophthalmol1980987120412107396771
   PubMedGoogle Scholar
• AbramsonDHRetinoblastoma 1990: diagnosis, treatment, and implicationsPediatr Ann19901963873952201000
   PubMed Web of Science ®Google Scholar
• DevesaSSThe incidence of retinoblastomaAm J Ophthalmol19758022632651155565
   PubMed Web of Science ®Google Scholar
• AbramsonDHRetinoblastoma in the 20th century: past success and future challenges the Weisenfeld lectureInvest Ophthalmol Vis Sci20054682683269116043839
   PubMed Web of Science ®Google Scholar
• ShieldsCLMashayekhiAAuAKThe international classification of retinoblastoma predicts chemoreduction successOphthalmology2006113122276228016996605
   PubMed Web of Science ®Google Scholar
• ScheflerACCicciarelliNFeuerWToledanoSMurrayTGMacular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablationOphthalmology2007114116216917070578
   PubMed Web of Science ®Google Scholar
• ChanHSGallieBLMunierFLBeck PopovicMChemotherapy for retinoblastomaOphthalmol Clin North Am20051815563viii15763191
   PubMedGoogle Scholar
• WhiteLThe role of chemotherapy in the treatment of retinoblastomaRetina1983331941996356260
   PubMed Web of Science ®Google Scholar
• WhiteLChemotherapy in retinoblastoma: current status and future directionsAm J Pediatr Hematol Oncol19911321892012069230
   PubMedGoogle Scholar
• EttingerLJGaynonPSKrailoMDA phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer GroupCancer1994734129713018313334
   PubMed Web of Science ®Google Scholar
• DozFPinkertonRWhat is the place of carboplatin in paediatric oncology?Eur J Cancer199430A21942018155394
   PubMed Web of Science ®Google Scholar
• TuckerMAD’AngioGJBoiceJDJrBone sarcomas linked to radiotherapy and chemotherapy in childrenN Engl J Med1987317105885933475572
   PubMed Web of Science ®Google Scholar
• BenzMSScottIUMurrayTGKramerDToledanoSComplications of systemic chemotherapy as treatment of retinoblastomaArch Ophthalmol2000118457757810766148
   PubMedGoogle Scholar
• GombosDSHungerfordJAbramsonDHSecondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?Ophthalmology200711471378138317613328
   PubMed Web of Science ®Google Scholar
• ScottIUMurrayTGFeuerWJExternal beam radiotherapy in retinoblastoma: tumor control and comparison of 2 techniquesArch Ophthalmol1999117676677010369587
   PubMedGoogle Scholar
• EngCLiFPAbramsonDHMortality from second tumors among long-term survivors of retinoblastomaJ Natl Cancer Inst19938514112111288320741
   PubMedGoogle Scholar
• BissellMJRadiskyDCRizkiAWeaverVMPetersenOWThe organizing principle: microenvironmental influences in the normal and malignant breastDifferentiation2002709–1053754612492495
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAThe hallmarks of cancerCell20001001577010647931
   PubMed Web of Science ®Google Scholar
• DewhirstMWCaoYMoellerBCycling hypoxia and free radicals regulate angiogenesis and radiotherapy responseNat Rev Cancer20088642543718500244
   PubMed Web of Science ®Google Scholar
• BushRSJenkinRDAlltWEDef initive evidence for hypoxic cells influencing cure in cancer therapyBr J Cancer Suppl19783302306277250
   PubMedGoogle Scholar
• ShannonAMBouchier-HayesDJCondronCMToomeyDTumour hypoxia, chemotherapeutic resistance and hypoxia-related therapiesCancer Treat Rev200329429730712927570
   PubMed Web of Science ®Google Scholar
• TeicherBAHypoxia and drug resistanceCancer Metastasis Rev19941321391687923547
   PubMed Web of Science ®Google Scholar
• WoutersBGKoritzinskyMHypoxia signalling through mTOR and the unfolded protein response in cancerNat Rev Cancer200881185186418846101
   PubMed Web of Science ®Google Scholar
• BoutridHJockovichMEMurrayTGTargeting hypoxia, a novel treatment for advanced retinoblastomaInvest Ophthalmol Vis Sci20084972799280518326690
   PubMed Web of Science ®Google Scholar
• JockovichMEMurrayTGEscalona-BenzEHernandezEFeuerWAnecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of LH(BETA)T(AG) miceInvest Ophthalmol Vis Sci20064741264126816565356
   PubMed Web of Science ®Google Scholar
• MerchanJRKovacsKRailsbackJWAntiangiogenic activity of 2-deoxy-D-glucosePLOSone2010510e13699
   Web of Science ®Google Scholar
• WindleJJAlbertDMO’BrienJMRetinoblastoma in transgenic miceNature199034362596656691689463
   PubMed Web of Science ®Google Scholar
• VariaMACalkins-AdamsDPRinkerLHPimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinomaGynecol Oncol19987122702779826471
   PubMed Web of Science ®Google Scholar
• LaitinenLGriffonia simplicifolia lectins bind specifically to endothelial cells and some epithelial cells in mouse tissuesHistochem J19871942252343597137
   PubMedGoogle Scholar
• NehlsVDrenckhahnDHeterogeneity of microvascular pericytes for smooth muscle type alpha-actinJ Cell Biol199111311471542007619
   PubMed Web of Science ®Google Scholar
• TanakaFOtakeYYanagiharaKEvaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibodyClin Cancer Res20017113410341511705856
   PubMed Web of Science ®Google Scholar
• SemenzaGLWangGLA nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activationMol Cell Biol19921212544754541448077
   PubMed Web of Science ®Google Scholar
• WangGLJiangBHRueEASemenzaGLHypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tensionProc Natl Acad Sci U S A19959212551055147539918
   PubMed Web of Science ®Google Scholar
• MaxwellPHPughCWRatcliffePJActivation of the HIF pathway in cancerCurr Opin Genet Dev200111329329911377966
   PubMed Web of Science ®Google Scholar
• RademakersSESpanPNKaandersJHSweepFCvan der KogelAJBussinkJMolecular aspects of tumour hypoxiaMol Oncol200821415319383328
   PubMed Web of Science ®Google Scholar
• JockovichMEBajenaruMLPinaYRetinoblastoma tumor vessel maturation impacts efficacy of vessel targeting in the LH(BETA)T(AG) mouse modelInvest Ophthalmol Vis Sci20074862476248217525173
   PubMed Web of Science ®Google Scholar
• CulicOGruwelMLSchraderJEnergy turnover of vascular endothelial cellsAm J Physiol19972731 Pt 1C205C2139252458
   PubMed Web of Science ®Google Scholar
• DobrinaASoranzoMRRossiFIsolation of metabolically active endothelial cells in high yield from bovine cavernous bodies. A model for functional studies on freshly isolated microvascular endothelial cellsCell Tissue Res198323235795916883458
   PubMed Web of Science ®Google Scholar
• PetersKKampGBerzAChanges in human endothelial cell energy metabolic capacities during in vitro cultivation. The role of “aerobic glycolysis” and proliferationCell Physiol Biochem2009245–648349219910688
   PubMedGoogle Scholar
• BajenaruMLPinaYMurrayTGGelatinase expression in retinoblastoma: modulation of LH(BETA)T(AG) retinal tumor development by anecortave acetateInvest Ophthalmol Vis Sci20105162860286420107171
   PubMed Web of Science ®Google Scholar
• DeryuginaEIQuigleyJPMatrix metalloproteinases and tumor metastasisCancer Metastasis Rev200625193416680569
   PubMed Web of Science ®Google Scholar
• PennJSRajaratnamVSCollierRJClarkAFThe effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurityInvest Ophthalmol Vis Sci200142128329011133880
   PubMed Web of Science ®Google Scholar
• BoutridHPinaYCebullaCMIncreased hypoxia following vessel targeting in a murine model of retinoblastomaInvest Ophthalmol Vis Sci200950125537554319578014
   PubMed Web of Science ®Google Scholar
• WatsonJDTo fight cancer, know the enemyNew York Times2009Aug 5
   Google Scholar